Table 2 Steroid dosage of patients with SLE during the index period
Parameter | Steroid dosagea | |||
|---|---|---|---|---|
0 mg/day | 0–7.5 mg/day | 7.5–20 mg/day | >20 mg/day | |
N (%) | 208 (19.8%) | 325 (30.9%) | 318 (30.3%) | 200 (19.0%) |
Female,n(%) | 186 (89.4%) | 280 (86.2%) | 270 (89.4%) | 158 (79.0%) |
Median age at diagnosis date (years) | 46.5 | 51.9 | 45.3 | 39.2 |
Mean CCI (SD) within 2 years | ||||
Prior to index period | 1.6 (1.8) | 2.1 (2.1) | 1.8 (2.0) | 1.5 (1.8) |
Post-index period | 2.7 (2.0) | 3.0 (2.2) | 2.7 (2.1) | 2.5 (1.7) |
Death during follow-up, n (%) | 15 (7.2%) | 26 (8.0%) | 32 (10.1%) | 13 (6.5%) |